116 3rd St SE
Cedar Rapids, Iowa 52401
KemPharm, Inc. Expands ADHD Pipeline With Discovery of KP415
Iowa City Area Development Group
Aug. 30, 2011 2:15 pm
KemPharm, Inc. ("KemPharm") of North Liberty announced it plans to initiate development of its recently identified lead compound KP415, a first-in-class prodrug of methylphenidate, which is a commonly used medication for the treatment of attention-deficit hyperactivity disorder (ADHD).
Read the full story at www.icadgroup.com/news (click the story headline).
Daily Newsletters